| Characteristic | Percentage of value |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
More information
Region
Worldwide
Survey time period
as of September 2017
Supplementary notes
* Biotech sector seems smaller than some might have expected. This is because the source classifies a company with no approved product as a 鈥渂iotechnology company鈥 and a company with a marketed product that is not a big pharma, not a Japan pharma nor a China pharma as a specialty pharma company. Thus, many companies (think Incyte) that some would think of as biotech are classified as specialty pharma.
Citation formats
